{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=227005&tablingMemberConstituency=Sutton+and+Cheam&version=2", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?identifier=227005&tablingMemberConstituency=Sutton+and+Cheam&version=2", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=227005&tablingMemberConstituency=Sutton+and+Cheam&_metadata=all&version=2", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=227005&_page=0&tablingMemberConstituency=Sutton+and+Cheam&version=2", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=227005&tablingMemberConstituency=Sutton+and+Cheam&version=2", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=227005&tablingMemberConstituency=Sutton+and+Cheam&version=2", "items" : [{"_about" : "http://data.parliament.uk/resources/226318", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/226318/answer", "answerText" : {"_value" : "<p>NHS England has advised that its Neuroscience Clinical Reference Group\u2019s recommendation was to approve the clinical policy to support the routine commissioning of levodopa-carpidopa intestinal gel for advanced Parkinson\u2019s disease and to go out to full public consultation.<\/p><p> <\/p><p> <\/p><p> <\/p><p>The recommendation related to an in year commissioning decision.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2015-03-17", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2015-03-17T15:53:34.2Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2015-03-10", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Co-careldopa"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 2 March 2015 to Question 224941, what the precise recommendation made by the Clinical Reference Group referred to in that Answer was; whether that recommendation related to (a) in year or (b) ongoing routine commissioning; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/204", "label" : {"_value" : "Biography information for Paul Burstow"}
      }
      , "tablingMemberConstituency" : {"_value" : "Sutton and Cheam"}
      , "tablingMemberPrinted" : [{"_value" : "Paul Burstow"}
      ], "uin" : "227005"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}